Daniel E. Fürst
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies 133
- Systemic Lupus Erythematosus Research 54
- Hematology top 0.05%
- Autoimmune and Inflammatory Disorders Research 41
- Pathology and Forensic Medicine top 0.05%
- Systemic Sclerosis and Related Diseases 69
- Lymphoma Diagnosis and Treatment 22
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 31
- Immunology top 0.2%
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 28
-
- Inflammatory Myopathies and Dermatomyositis 20
- Co-authors
- Michael H. WeismanPeter E. LipskyRavinder N. MainiPaul EmeryE. William St. ClairJoachim R. KaldenMarc FeldmannGregory R. Harriman
- Journals
- Annals of the Rheumatic Diseases (35 papers)Lara D. Veeken (16 papers)The Journal of Rheumatology (15 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Daniel E. Fürst
254 papers receiving 21.2k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Rheumatology 12.3k
- Hematology 5.3k
- Pathology and Forensic Medicine 5.0k
- Genetics 2.6k
- Immunology 4.6k
Countries citing papers authored by Daniel E. Fürst
This map shows the geographic impact of Daniel E. Fürst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Fürst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Fürst more than expected).
Fields of papers citing papers by Daniel E. Fürst
This network shows the impact of papers produced by Daniel E. Fürst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Fürst. The network helps show where Daniel E. Fürst may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel E. Fürst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 21 | |
| 4 | 2019 | 6 | |
| 5 | 2018 | 12 | |
| 6 | 2017 | 1 | |
| 7 | 2013 | 26 | |
| 8 | 2012 | 241 | |
| 9 | 2011 | 53 | |
| 10 | 2011 | 17 | |
| 11 | 2010 | 34 | |
| 12 | 2009 | 5 | |
| 13 | 2008 | 58 | |
| 14 | 2008 | 23 | |
| 15 | 2007 | 30 | |
| 16 | Recombinant Human Relaxin in the Treatment of Scleroderma | 2000 | 44 |
| 17 | 1999 | 355 | |
| 18 | 1995 | 25 | |
| 19 | 1994 | 12 | |
| 20 | Nonsteroidal anti-inflammatory drugs : mechanisms and clinical use | 1987 | 41 |
About Daniel E. Fürst
Daniel E. Fürst is a scholar working on Rheumatology, Pathology and Forensic Medicine and Hematology, having authored 258 papers that have together received 22.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (133 papers), Systemic Sclerosis and Related Diseases (69 papers), Systemic Lupus Erythematosus Research (54 papers), Autoimmune and Inflammatory Disorders Research (41 papers), Chronic Lymphocytic Leukemia Research (31 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (28 papers), Lymphoma Diagnosis and Treatment (22 papers) and Inflammatory Myopathies and Dermatomyositis (20 papers). The work is most often cited by research in Rheumatology (12.3k citations), Hematology (5.3k citations) and Pathology and Forensic Medicine (5.0k citations). Daniel E. Fürst has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Michael H. Weisman, Peter E. Lipsky, Ravinder N. Maini, Paul Emery, E. William St. Clair, Joachim R. Kalden, Marc Feldmann, Gregory R. Harriman, Ferdinand C. Breedveld and Josef S Smolen. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, The Journal of Rheumatology, Seminars in Arthritis and Rheumatism and Arthritis Care & Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.